Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Janet C. Lynn is active.

Publication


Featured researches published by Janet C. Lynn.


Bioorganic & Medicinal Chemistry Letters | 2001

Identification of novel potent hydroxamic acid inhibitors of peptidyl deformylase and the importance of the hydroxamic acid functionality on inhibition

Atli Thorarensen; Martin R. Douglas; Douglas C. Rohrer; Anne F. Vosters; Anthony W. Yem; Vincent D. Marshall; Janet C. Lynn; Michael John Bohanon; Paul K. Tomich; Gary E. Zurenko; Michael T. Sweeney; Randy M. Jensen; James W. Nielsen; Eric P. Seest; Lester A. Dolak

Peptidyl deformylase (PDF) is a metallo protease that catalyzes the removal of a formyl group from the N-termini of prokaryotic prepared polypeptides, an essential step in bacterial protein synthesis. Screening of our compound collection using Staphylococcus aureus PDF afforded a very potent inhibitor with an IC(50) in the low nanomolar range. Unfortunately, the compound that contains a hydroxamic acid did not exhibit antibacterial activity (MIC). In order to address the lack of activity in the MIC assay and to determine what portion of the molecule was responsible for binding to PDF, we prepared several analogues. This paper describes our findings that the hydroxamic acid functionality found in 1 is mainly responsible for the high affinity to PDF. In addition, we identified an alternative class of PDF inhibitors, the N-hydroxy urea 18, which has both PDF and antibacterial activity.


Bioorganic & Medicinal Chemistry Letters | 2001

Corrigendum to “Identification of novel potent hydroxamic acid inhibitors of peptidyl deformylase and the importance of the hydroxamic acid functionality on inhibition” [Bioorg. Med. Chem. Lett. 11 (2001) 1355]†

Atli Thorarensen; Martin R. Deibel; Douglas C. Rohrer; Anne F. Vosters; Anthony W. Yem; Vincent D. Marshall; Janet C. Lynn; Michael John Bohanon; Paul K. Tomich; Gary E. Zurenko; Michael T. Sweeney; Randy M. Jensen; James W. Nielsen; Eric P. Seest; Lester A. Dolak

Medicinal Chemistry 7254-209-615, Pharmacia, Kalamazoo, MI 49001-0199, USA Protein Science, Pharmacia, Kalamazoo, MI 49001-0199, USA Computer Aided Drug Discovery Research, Pharmacia, Kalamazoo, MI 49001-0199, USA Discovery Technologies, Pharmacia, Kalamazoo, MI 49001-0199, USA Biology I, Pharmacia, Kalamazoo, MI 49001-0199, USA Structural, Analytical & Medicinal Chemistry Research, Pharmacia, Kalamazoo, MI 49001-0199, USA


Bioorganic & Medicinal Chemistry Letters | 1997

Synthesis and pharmacological evaluation of sulfone substituted HIV protease inhibitors

Theresa M. Schwartz; Gordon L. Bundy; Joseph Walter Strohbach; Suvit Thaisrivongs; Paul D. Johnson; Harvey I. Skulnick; Paul K. Tomich; Janet C. Lynn; Kong Teck Chong; Roger R. Hinshaw; Thomas J. Raub; Guy E. Padbury; Lisa N. Toth

Abstract The sulfonamide substituted pyranones ( 1 ) have recently been shown to be potent HIV protease inhibitors. We prepared a series of sulfone substituted analogs and compared their biological activities to those of the corresponding sulfonamide analogs. It was determined that although these compounds maintained activity as enzyme inhibitors, they showed somewhat diminished antiviral activity even though they may possess increased membrane permeability.


Journal of Medicinal Chemistry | 1998

Tipranavir (PNU-140690): A Potent, Orally Bioavailable Nonpeptidic HIV Protease Inhibitor of the 5,6-Dihydro-4-hydroxy-2-pyrone Sulfonamide Class∇

Steve R. Turner; Joseph Walter Strohbach; Ruben Tommasi; Paul A. Aristoff; Paul D. Johnson; Harvey I. Skulnick; Lester A. Dolak; Eric P. Seest; Paul K. Tomich; Michael John Bohanon; Miao-Miao Horng; Janet C. Lynn; Chong Kt; Roger R. Hinshaw; Keith D. Watenpaugh; Musiri N. Janakiraman; Suvit Thaisrivongs


Journal of Medicinal Chemistry | 1995

Structure-based design of novel HIV protease inhibitors: carboxamide-containing 4-hydroxycoumarins and 4-hydroxy-2-pyrones as potent nonpeptidic inhibitors.

Suvit Thaisrivongs; Keith D. Watenpaugh; Howe Wj; Paul K. Tomich; Lester A. Dolak; Chong Kt; C.-S. C. Tomich; Alfredo G. Tomasselli; Steven Ronald Turner; Joseph Walter Strohbach; A. M. Mulichak; Musiri N. Janakiraman; Joseph B. Moon; Janet C. Lynn; Miao-Miao Horng; Roger R. Hinshaw; Kimberly A. Curry; D. J. Rothrock


Journal of Medicinal Chemistry | 1996

Structure-based design of HIV protease inhibitors: sulfonamide-containing 5,6-dihydro-4-hydroxy-2-pyrones as non-peptidic inhibitors.

Suvit Thaisrivongs; Harvey I. Skulnick; Steven Ronald Turner; Joseph Walter Strohbach; Ruben A Tommasi; Paul D. Johnson; Paul A. Aristoff; T.M Judge; Ronald B. Gammill; Joel Morris; K.R Romines; R.A Chrusciel; Roger R. Hinshaw; Chong Kt; W.G Tarpley; S.M Poppe; D.E Slade; Janet C. Lynn; Miao-Miao Horng; Paul K. Tomich; Eric P. Seest; Lester A. Dolak; Howe Wj; G.M Howard; Keith D. Watenpaugh


Journal of Medicinal Chemistry | 1997

Structure-based design of nonpeptidic HIV protease inhibitors: the sulfonamide-substituted cyclooctylpyramones.

Harvey I. Skulnick; Paul D. Johnson; Paul A. Aristoff; Morris Jk; Lovasz Kd; Howe Wj; Keith D. Watenpaugh; M.N Janakiraman; D.J Anderson; R.J Reischer; T.M Schwartz; L.S Banitt; Paul K. Tomich; Janet C. Lynn; Miao-Miao Horng; Chong Kt; Roger R. Hinshaw; Lester A. Dolak; Eric P. Seest; Francis J. Schwende; Bob D. Rush; G.M Howard; L.N Toth; K.R Wilkinson; T.J Kakuk; C.W Johnson; S.L Cole; R.M Zaya; G.L Zipp; P.L Possert


Journal of Medicinal Chemistry | 1996

Structure-based design of HIV protease inhibitors: 5,6-dihydro-4- hydroxy-2-pyrones as effective, nonpeptidic inhibitors

Suvit Thaisrivongs; Donna Lee Romero; Ruben A Tommasi; Musiri N. Janakiraman; Joseph Walter Strohbach; Steve R. Turner; Carolyn Biles; Raymond R. Morge; Paul D. Johnson; Paul Adrian Aristoff; Paul K. Tomich; Janet C. Lynn; Miao Miao Horng; Kong Teck Chong; Roger R. Hinshaw; W. Jeffrey Howe; Barry C. Finzel; Keith D. Watenpaugh


Journal of Medicinal Chemistry | 1995

Structure-Based Design of Sulfonamide-Substituted Non-Peptidic HIV Protease Inhibitors

Harvey I. Skulnick; Paul D. Johnson; Howe Wj; Paul K. Tomich; Chong Kt; Keith D. Watenpaugh; Musiri N. Janakiraman; Lester A. Dolak; McGrath Jp; Janet C. Lynn


Journal of Medicinal Chemistry | 1995

Use of medium-sized cycloalkyl rings to enhance secondary binding: discovery of a new class of human immunodeficiency virus (HIV) protease inhibitors.

Romines Kr; Keith D. Watenpaugh; Paul K. Tomich; Howe Wj; Morris Jk; Lovasz Kd; A. M. Mulichak; Barry C. Finzel; Janet C. Lynn; Miao-Miao Horng; Francis J. Schwende; M. J. Ruwart; G.L Zipp; Chong Kt; L. A. Dolak; L.N Toth; G.M Howard; Bob D. Rush; Karen F. Wilkinson; P.L Possert; R.J Dalga; Roger R. Hinshaw

Collaboration


Dive into the Janet C. Lynn's collaboration.

Researchain Logo
Decentralizing Knowledge